Anthony Charles Minson

Title: Innovations of Anthony Charles Minson

Introduction

Anthony Charles Minson is a notable inventor based in Great Shelford, GB. He has made significant contributions to the field of viral vaccines, holding a total of five patents. His work focuses on developing mutant viruses that can be used for prophylaxis or therapy against infectious diseases.

Latest Patents

One of his latest patents involves a mutant virus designed for use as a vaccine. This virus has a genome that is defective in a gene essential for producing infectious virus. The mutant virus, such as a herpesvirus, is capable of protecting a susceptible species immunized with it against infection by the corresponding wild-type virus. Additionally, the mutant virus can act as a vector for an immunogenic protein derived from a pathogen, which is encoded by foreign DNA incorporated into the mutant virus. The production of this mutant virus can occur in a recombinant host cell that expresses a gene complementing the defect. The mutant virus can be infectious for the host to be protected, allowing for the expression of some viral genes that can provoke a cell-mediated immune response.

Career Highlights

Throughout his career, Anthony has worked with various companies, including Cantab Pharmaceuticals Research Limited and Xenova Research Limited. His innovative approaches to vaccine development have positioned him as a key figure in the field of immunology.

Collaborations

Anthony has collaborated with notable individuals in his field, including Stephen Charles Inglis and Michael Edward Boursnell. These collaborations have further enhanced his research and contributions to vaccine technology.

Conclusion

Anthony Charles Minson's work in developing mutant viruses for use as vaccines represents a significant advancement in the fight against infectious diseases. His innovative patents and collaborations highlight his dedication to improving public health through scientific research.